Home | Infections | HIV and AIDS

HIV and AIDS

Harm-Reduction Program Optimizes HIV/AIDS Prevention, UCSF Study Shows

By Jeff Sheehy -New research from UC San Francisco and the San Francisco AIDS Foundation has found that clients participating in a ...

Gender, sexuality and marriage as risk factor for HIV infection topic at Rice April 24

Jennifer Hirsch, a leading scholar on gender, sexuality and reproductive health, will discuss marriage as a risk factor for HIV infection as ...

More Research called for into HIV and schistosomiasis coinfection in African children

Researchers from LSTM have called for more research to be carried out into HIV and schistosomiasis coinfection in children in sub-Saharan Africa. ... Full story

Tracking the HI Virus with High-resolution Microscopy

BMBF funds joint project to develop new microscopy methods ... Full story

HIV+ women respond well to HPV vaccine

A three-nation clinical trial found that a vaccine can safely help the vast majority of HIV-positive women produce antibodies against the cancer-causing human papillomavirus, even if their immune system is weak and even if they’ve had some prior HPV exposure. ... Full story

NYU Researchers Find Computerized Counseling Reduces HIV-1 Viral Load and Sexual Transmission Risk

Researchers found computerized intervention may aid antiretroviral therapy ... Full story

Community-based HIV prevention can boost testing, help reduce new infections

By Enrique Rivero - Communities in Africa and Thailand that worked together on HIV-prevention efforts saw not only a rise in HIV screening but a drop in new infections, according to a new study in the peer-reviewed journal The Lancet Global Health. ... Full story

HIV battle must focus on hard-hit streets

“Do One Thing” – get tested Knowing one’s HIV and hepatitis C status is a significant step toward treatment and controlling the spread of disease. Door-to-door efforts like Philadelphia’s “Do One Thing” help, but more resources for testing and treatment need to target communities that need them most. ... Full story

Nano-sized drug particles to expand HIV treatment further

Dr Paul L. Domanico: “This project partners two substantial organisations committed to transforming the treatment of disease for patients in low resource settings” ... Full story

Future HIV Vaccine Research Must Consider Both Protective Immune Responses and Those that Might Increase Susceptibility to Infection

WHAT: Last year, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, held a scientific meeting to examine why certain investigational HIV vaccines may have increased susceptibility to HIV infection. ... Full story

1 2 3 4 5 6 7 8 9 10 next last total: 169 | displaying: 1 - 10